Help me find a form for health professionals

We can help you find a form based on your role and tasks.

Select one or more of the options that apply to you.

When you post or fax a form to us you need to sign the manual form. We can't accept digital signatures with paper forms.

When you send a form to us through HPOS, we can accept digital signatures attached to electronic forms.

My role is
I want to
The form is for
Code Title
PB042 Aboriginal Health Services (AHS) pharmaceutical supplies request
PB181 Acromegaly - pasireotide initial PBS authority application
PB225 Acromegaly - pegvisomant initial PBS authority application
PB210 Acute lymphoblastic leukaemia - blinatumomab - initial (induction) authority application
PB271 Acute lymphoblastic leukaemia - first line - dasatinib initial PBS authority application
PB269 Acute lymphoblastic leukaemia - inotuzumab ozogamicin initial (induction) authority application
PB169 Acute lymphoblastic leukaemia - ponatinib initial authority application
PB077 Acute lymphoblastic leukaemia - second line - dasatinib initial PBS authority application
PB253 Acute myeloid leukaemia - midostaurin - initial maintenance authority application
PB355 Acute myeloid leukaemia - oral azacitidine - dose escalation therapy continuing authority application
AC014 Aged care application for the dementia and cognition supplement in home care
AC021 Aged care entry record
AC001 Aged Care Funding Instrument - application for classification
AC004 Aged Care Provider Portal - Register, amend or remove users
PB251 Ankylosing spondylitis - change, recommencement or demonstration of response authority application
PB074 Ankylosing spondylitis - continuing authority application
PB073 Ankylosing spondylitis - initial authority application
PB352 Ankylosing spondylitis - tofacitinib - initial grandfather authority application
HW093 Application for a Medicare provider number and, or prescriber number for allied health and non-medical health professionals
HW088 Application for a Medicare provider number and/or PBS prescriber number for a midwife or nurse practitioner
HW019 Application for a Medicare provider number and/or prescriber number for a medical practitioner
HW001 Application for a PKI site certificate
HW011 Application for approval, amendment or renewal of an approved pathology authority
HW009 Application for approval, amendment or renewal of an approved pathology practitioner
HW010 Application for approval, amendment or renewal of premises as an accredited pathology laboratory
HW035 Application for approval, amendment, renewal or cancellation of an approved collection centre
DB018 Application for bulk bill claim adjustment
HW026 Application for late lodgement of a Simplified Billing claim for assigned Medicare benefits
HW077 Application for recognition as a specialist or consultant physician
HW065 Application for remote area exemption for R-type diagnostic imaging services for a medical practitioner
AC011 Application for the Oxygen or Enteral Feeding Supplement
AC015 Application to add or change approved care service's bank details
HW061 Application to register or amend a diagnostic imaging or radiation oncology practice
HW036 Approved Pathology Authority acquisition or merger advice
PB242 Approved supplier manual payment reconciliation
DB020 Assignment of benefit Medicare bulk bill Webclaim
PB125 Atypical haemolytic uraemic syndrome (aHUS) - eculizumab or ravulizumab - continuing authority application
PB119 Atypical haemolytic uraemic syndrome (aHUS) - eculizumab or ravulizumab - initial or switching authority application
PB176 Atypical haemolytic uraemic syndrome (aHUS) - eculizumab or ravulizumab - recommencement authority application
PB359 Atypical haemolytic uraemic syndrome (aHUS) - ravulizumab - initial grandfather authority application
IM004 Australian Immunisation Register (AIR) - application to register as a vaccination provider
IM005 Australian Immunisation Register (AIR) - bank account details for vaccination providers
IM017 Australian Immunisation Register (AIR) - ceasing correspondence and release of information
IM018 Australian Immunisation Register (AIR) - immunisation encounter
IM013 Australian Immunisation Register (AIR) - immunisation history
IM011 Australian Immunisation Register (AIR) - immunisation medical exemption
HW052 Banking details online claiming
DB4E Bulk bill voucher - electronically transmitted claims
PB123 CD30 positive systemic anaplastic large cell lymphoma - brentuximab vedotin - initial authority application
SU415 Centrelink Medical Certificate
PB084 Chronic myeloid leukaemia - asciminib or ponatinib - continuing authority application
PB171 Chronic myeloid leukaemia - asciminib or ponatinib - initial authority application
PB079 Chronic myelomonocytic leukaemia - azacitidine - initial authority application
PB340 Chronic myelomonocytic leukaemia - decitabine+cedazuridine - initial authority application
PB348 Chronic rhinosinusitis with nasal polyps - mepolizumab - initial authority application
PB349 Chronic rhinosinusitis with nasal polyps - mepolizumab - initial grandfather authority application
PB193 Chronic thromboembolic pulmonary hypertension - riociguat - continuing authority application
PB192 Chronic thromboembolic pulmonary hypertension - riociguat - initial authority application
AC010 Consent to release an electronic Aged Care Client Record
MO065 COVID-19 Vaccine Claims Scheme cost calculation
PB239 Crohn's disease paediatric change or recommencement authority application
PB161 Crohn's disease paediatric continuing authority application
PB085 Crohn's disease paediatric initial authority application
PB235 Crohn’s disease adult - change, recommencement or demonstration of response authority application
PB088 Crohn’s disease adult - continuing authority application
PB087 Crohn’s disease adult - initial authority application
PB357 Crohn’s disease adult - upadacitinib - initial grandfather authority application
PB268 Cutaneous T-cell lymphoma (CTCL) - brentuximab vedotin - initial authority application
PB216 Cutaneous T-cell lymphoma (CTCL) - vorinostat - initial authority application
PB287 Cystic fibrosis - elexacaftor+tezacaftor+ivacaftor - continuing authority application
PB286 Cystic fibrosis - elexacaftor+tezacaftor+ivacaftor - initial authority application
PB126 Cystic fibrosis - ivacaftor - continuing authority application
PB120 Cystic fibrosis - ivacaftor - initial authority application
PB244 Cystic fibrosis - lumacaftor+ivacaftor or tezacaftor+ivacaftor - continuing authority application
PB243 Cystic fibrosis - lumacaftor+ivacaftor or tezacaftor+ivacaftor - initial authority application
PB346 Diabetic macular oedema - faricimab - initial grandfather authority application
PB155 Diabetic macular oedema - initial authority application
SA478 Disability Support Pension Medical Evidence Checklist for treating health professionals
PB289 Early HER2 positive breast cancer - trastuzumab emtansine - initial authority application
PB093 Fistulising Crohn's disease - continuing authority application
PB092 Fistulising Crohn's disease - initial, grandfather, or recommencement (treatment break greater than 5 years) authority application
PB236 Fistulising Crohn’s disease - change, recommencement (treatment break less than 5 years) or demonstration of response authority application
PB096 Gastrointestinal stromal tumour - sunitinib - initial authority application
PB294 General (S85) Schedule - opioid treatment authority application
HW074 General practitioner 90 day pay doctor cheque scheme application
IP011 General Practitioner Aged Care Access Incentive Payment banking details
PB272 Giant cell arteritis - tocilizumab - initial authority application
PB288 Growth hormone deficiency - childhood onset initial authority application
PB248 Growth hormone deficiency - somatropin - late onset initial authority application
PB165 Growth hormone paediatric - change or recommencement authority application
PB164 Growth hormone paediatric - continuing as a reclassified patient authority application
PB163 Growth hormone paediatric - continuing authority application
PB162 Growth hormone paediatric - initial authority application
PB166 Growth hormone paediatric - recommencement as a reclassified patient authority application
PB339 Growth hormone paediatric - somatrogon - initial grandfather authority application
HW048 Healthcare Identifiers Service application to deactivate or retire a contracted service provider organisation
PB325 Hereditary angioedema type 1 or 2 - lanadelumab - initial authority application
HW046 HI Service - application to add, replace or remove a contracted service provider officer
HW047 HI Service - application to amend a contracted service provider officer's details
HW034 HI Service - application to amend a healthcare provider record
HW042 HI Service - application to amend an organisation officer's personal details
HW043 HI Service - application to amend details of a contracted service provider organisation record
HW044 HI Service - application to deactivate, reactivate or retire a healthcare organisation
HW013 HI Service - application to register a general supporting organisation
HW033 HI Service - application to register a healthcare provider
HW012 HI Service - My Health Record system - application to register a contracted service provider organisation record
PB208 Idiopathic pulmonary fibrosis - initial authority application
PB351 Idiopathic thrombocytopenic purpura - avatrombopag - initial grandfather authority application
PB097 Idiopathic thrombocytopenic purpura - initial authority application
PB323 Juvenile idiopathic arthritis - change of treatment after resolution of critical shortage of tocilizumab authority application
PB282 Juvenile idiopathic arthritis for adult patients with onset prior to age 18 change or recommencement or demonstration of response authority application
PB063 Juvenile idiopathic arthritis for adult patients with onset prior to age 18 continuing authority application
PB062 Juvenile idiopathic arthritis for adult patients with onset prior to age 18 initial authority application
HW080 Manual identity verification for Provider Digital Access
PB259 Manual Prescription processing fee
MO008 Medical indemnity request to aggregate payments for the same claim
HW059 Medicare Easyclaim enquiry
DB6Ba Medicare stationery order
PB302 Medicine export declaration
PB099 Metastatic HER2 positive breast cancer - lapatinib - initial authority application
PB207 Metastatic or locally advanced basal cell carcinoma - sonidegib or vismodegib - continuing authority application
PB206 Metastatic or locally advanced basal cell carcinoma - sonidegib or vismodegib - initial authority application
PB219 Moderate to severe hidradenitis suppurativa continuing authority application
PB218 Moderate to severe hidradenitis suppurativa initial authority application
PB214 Multiple myeloma dual therapy - pomalidomide - initial authority application
PB200 Multiple myeloma newly diagnosed dual therapy - lenalidomide - initial authority application
PB291 Multiple myeloma newly diagnosed monotherapy - lenalidomide - initial authority application
PB293 Multiple myeloma newly diagnosed triple therapy - lenalidomide - initial authority application
PB158 Multiple myeloma progressive disease - lenalidomide - initial authority application
PB012 Myelodysplastic syndrome - lenalidomide - initial or first continuing authority application
PB172 Myelofibrosis - ruxolitinib - initial authority application
PB104 Narcolepsy without cataplexy - armodafinil or modafinil initial authority application
PB255 Non-radiographic axial spondyloarthritis - initial authority application
PB353 Non-radiographic axial spondyloarthritis - upadacitinib - initial grandfather authority application
PB156 Non-small cell lung cancer - crizotinib or entrectinib - initial authority application
HW055 Notification of Australian Business Number and reference identification for tax treatment purposes and recipient created tax invoice agreement
PB019 Notification of bank account details for Aboriginal Health Services program payments
HW027 Online claiming provider agreement
PB229 Order for PBS or RPBS computer prescription forms for all eligible prescribers
PB283 Order for PBS/RPBS prescription pads for all eligible prescribers
PB306 Palliative Care Schedule - opioid treatment authority application
PB328 Paroxysmal nocturnal haemoglobinuria - eculizumab or ravulizumab - continuing authority application
PB329 Paroxysmal nocturnal haemoglobinuria - eculizumab or ravulizumab - initial grandfather authority application
PB327 Paroxysmal nocturnal haemoglobinuria - eculizumab or ravulizumab - initial, switching, returning or balance of supply authority application
PB344 Paroxysmal nocturnal haemoglobinuria - pegcetacoplan - continuing or returning authority application
PB343 Paroxysmal nocturnal haemoglobinuria - pegcetacoplan - initial authority application
PB345 Paroxysmal nocturnal haemoglobinuria - pegcetacoplan - initial grandfather authority application
PB114 PASI calculation and body diagram - face, hand and foot
PB115 PASI calculation and body diagram - whole body
PB241 PBS Safety Net claim for payment
PB314 Peripheral T-cell lymphoma (PTCL) - brentuximab vedotin - initial authority application
HW064 Positron emission tomography - statutory declaration
IP025 Practice Incentives Additional practice branch
IP001 Practice Incentives application
IP005 Practice Incentives change of practice details
IP010 Practice Incentives Change of practice ownership
IP003 Practice Incentives individual general practitioner, nurse practitioner or health professional details
IP007 Practice Incentives Practice closure or withdrawal
IP008 Practice Incentives practice ownership details and declaration
IP030 Practice Incentives Program After Hours Incentive application
IP017 Practice Incentives Program Indigenous Health Incentive patient registration and consent
IP029 Practice Incentives Program Indigenous Health Incentive patient withdrawal of consent
IP026 Practice Incentives Program Indigenous Health Incentive practice application
IP004 Practice Incentives Program Procedural General Practitioner Payment application
IP006 Practice Incentives Program Teaching Payment claim
IP027 Practice Incentives review of decision
HW081 Private health insurer registrations and updates for ECLIPSE
PB332 Progressive fibrosing interstitial lung disease - nintedanib - initial authority application
MO003 Provider Directory Data authorised recipient data release application or renewal
HW029 Provider registration for Electronic Funds Transfer payments
PB260 Psoriatic arthritis - change, recommencement or demonstration of response authority application
PB106 Psoriatic arthritis - continuing authority application
PB105 Psoriatic arthritis - initial authority application
PB303 Pulmonary arterial hypertension - initial dual or triple therapy authority application
PB301 Pulmonary arterial hypertension - initial grandfather dual or triple therapy authority application
PB070 Pulmonary arterial hypertension - initial monotherapy authority application
AC027 Register or update for Aged Care web services
PB205 Relapsed or refractory Hodgkin lymphoma - brentuximab vedotin - initial authority application
HW078 Request for pay group link
PB157 Request for prescriber bag supplies order book
HW003 Request to renew, revoke or reissue a Public Key Infrastructure certificate
HW083 Request to revoke or reissue a NASH PKI certificate
PB154 Retinal vein occlusion - initial authority application
PB324 Rheumatoid arthritis - change of treatment after resolution of critical shortage of tocilizumab authority application
PB247 Rheumatoid arthritis - change, recommencement or demonstration of response authority application
PB111 Rheumatoid arthritis - continuing authority application
PB109 Rheumatoid arthritis - initial authority application
MO043 ROCS - midwife medical certificate for maternity
MO060 ROCS - midwife medical certificate for permanent disability
MO032 Run off Cover Indemnity Scheme - medical certificate maternity
MO056 Run off Cover Indemnity Scheme - medical certificate permanent disability
PB136 Seemingly valid Medicare card
PB189 Severe allergic asthma paediatric - omalizumab - continuing authority application
PB188 Severe allergic asthma paediatric - omalizumab - initial authority application
PB285 Severe asthma - adolescent and adult - change authority application
PB076 Severe asthma - adolescent and adult - continuing authority application
PB075 Severe asthma - adolescent and adult - initial or recommencement after 12 months break authority application
PB356 Severe chronic plaque psoriasis - bimekizumab - initial grandfather authority application
PB263 Severe chronic plaque psoriasis - change, recommencement or demonstration of response authority application
PB113 Severe chronic plaque psoriasis - continuing authority application
PB112 Severe chronic plaque psoriasis - initial authority application
PB319 Severe chronic plaque psoriasis - ustekinumab - for patients under 18 years continuing authority application
PB320 Severe chronic plaque psoriasis ustekinumab - for patients under 18 years initial, change, recommencement or demonstration of response authority application
PB223 Severe chronic spontaneous urticaria - omalizumab - initial authority application
PB337 Severe growth failure with primary insulin-like growth factor-1 deficiency - mecasermin - continuing authority application
PB336 Severe growth failure with primary insulin-like growth factor-1 deficiency - mecasermin - initial authority application
PB338 Severe growth failure with primary insulin-like growth factor-1 deficiency - mecasermin - initial grandfather authority application
PB276 Short bowel syndrome with intestinal failure - teduglutide - continuing authority application
PB275 Short bowel syndrome with intestinal failure - teduglutide - initial authority application
HW091 Simplified Billing manual claims batch header
HW023 Simplified Billing or ECLIPSE adjustment claim
PB333 Solid tumours - NTRK gene fusion positive - larotrectinib - initial authority application
PB330 Spinal muscular atrophy - onasemnogene abeparvovec - authority application
PB334 Spinal muscular atrophy adult - nusinersen or risdiplam - initial authority application
PB233 Spinal muscular atrophy paediatric - nusinersen or risdiplam - initial authority application
MO042 Statutory declaration - Midwife Professional Indemnity Scheme - Online claim
MO033 Statutory declaration ROCS - Deceased medical practitioner
MO040 Statutory declaration ROCS - Deceased midwife
MO037 Statutory declaration ROCS - Medical practitioner who has ceased medical practice because of maternity
MO036 Statutory declaration ROCS - Medical practitioner who has ceased medical practice because of permanent disability
MO031 Statutory declaration ROCS - Medical practitioner who has ceased private or all remunerated medical practice due to retirement
MO034 Statutory declaration ROCS - Medical practitioner who has not engaged in either private or remunerated medical practice during the preceding 3 years
MO039 Statutory declaration ROCS - Midwife aged 65 years or older who has ceased practice
MO038 Statutory declaration ROCS - Midwife ceased practice because of permanent disability
MO044 Statutory declaration ROCS - Midwife engaged in a private practice
MO041 Statutory declaration ROCS - Midwife who has ceased practice
MO035 Statutory declaration ROCS - Overseas medical practitioner
PB347 Subfoveal choroidal neovascularisation - faricimab - initial grandfather authority application
PB072 Subfoveal choroidal neovascularisation - initial authority application
PB341 Systemic light chain amyloidosis - newly diagnosed - daratumumab - initial authority application
PB342 Systemic light chain amyloidosis - newly diagnosed - daratumumab - initial grandfather authority application
PB215 Ulcerative colitis - paediatric - initial authority application
PB245 Ulcerative colitis adult - change or recommencement authority application
PB127 Ulcerative colitis adult - initial authority application
PB350 Ulcerative colitis adult - initial grandfather authority application
PB246 Ulcerative colitis paediatric change or recommencement authority application
SA495 Verification of Terminal Illness
AC024 Viability expansion component and homeless supplement assessment
MO057 Voluntary acknowledgement of incorrect payments
IP020 Workforce Incentive Program - Doctor Stream - bank account details
Page last updated: 10 December 2021.
QC 90